|
|||||
|
|
Economic impact of 13‐valent pneumococcal conjugate vaccine in Finnish adults ≥50 years with underlying chronic medical conditions |
|
| Authors: | Janne A. Martikainen,Erkki J. Soini,Juha Laine,Heidi hman,Ville Postila,Peter Klemets |
| Affiliation: | 1. ESiOR Oy, , Kuopio, Finland;2. Pfizer Oy, , Helsinki, Finland;3. Porvoo Hospital, , Porvoo, Finland |
| Abstract: | |
| Keywords: | adult budget impact health care costs health economics invasive pneumococcal disease pneumococcal vaccine |